Healthcare >> CEO Interviews >> October 16, 2000
DR. ELLIOT F. HAHN is President and a Director of Andrx Corporation.
From June 1990 to February 1993, Dr. Hahn was employed as Vice
President, Scientific Affairs of IVAX, where he was involved in the
evaluation and international licensing of product opportunities and was
responsible for maintaining the intellectual property of IVAX. From 1988
to 1993, Dr. Hahn also served as the Vice President of Research of Baker
Norton Pharmaceuticals, a subsidiary of IVAX. Prior to that, he was an
Associate Professor at The Rockefeller University from 1977 to 1988.
From 1976 until 1978, Dr. Hahn was an Assistant Professor at Albert
Einstein College of Medicine and a member of the Institute for Steriod
Research at Montefiore Hospital in New York City. Since 1988, he has
been an adjunct Associate Professor at the University of Miami School of
Medicine. He currently serves on the Boards of several
pharmaceutical/medical companies. Dr. Hahn holds a BS degree from City
College of New York and a PhD degree in Chemistry from Cornell
University. He has authored over 60 original scientific papers and is
named as an inventor in a number of United States patents. Profile
ANGELO C. MALAHIAS joined Andrx as its Vice President and Chief
Financial Officer in January 1996. From January 1995 to January 1996,
Mr. Malahias was Vice President and Chief Financial Officer of Circa
Pharmaceuticals, where he also served as Corporate Controller from July
1994 to January 1995. From 1983 to July 1994, he was employed by KPMG
Peat Marwick LLP. Mr. Malahias is a Certified Public Accountant. Profile
Corporation?
Dr. Hahn: Andrx was started in the latter half of 1992 and continues to
be led by Alan Cohen who is Andrx's Chief
